Literature DB >> 373876

Clinical involvement of Aeromonas hydrophila.

T J Trust, D C Chipman.   

Abstract

Aeromonas hydrophila has for some time been regarded as an opportunistic pathogen in hosts with impaired local or general defence mechanisms. Infections in such individuals are generally severe. The organism is also being isolated with increasing frequency throughout the world from a variety of focal and systemic infections of varying severity in persons that are apparently immunologically normal. Most commonly it causes acute diarrheal disease by producing an enterotoxin. Thus the organism appears to have greater clinical significance that was hitherto suspected. The organism has been infrequently reported from humans in Canada, but its correct laboratory identification, together with increased awareness that it can contribute to illness, will undoubtedly lead to more reports of its isolation in Canada.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 373876      PMCID: PMC1819230     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  40 in total

1.  THE GENUS AEROMONAS: METHODS FOR IDENTIFICATION.

Authors:  M V MEEKS
Journal:  Am J Med Technol       Date:  1963 Nov-Dec

2.  A case of acute, metastatic, myositis caused by a new organism of the family: Pseudomonadaceae; a preliminary report.

Authors:  K R HILL; F H CASELITZ; L M MOODY
Journal:  West Indian Med J       Date:  1954-03       Impact factor: 0.171

3.  [On the problem of the significance of Aeromonas strains in enteritis in infants].

Authors:  R MARTINEZ-SILVA; M GUZMANN-URREGO; F H CASELITZ
Journal:  Z Tropenmed Parasitol       Date:  1961-12

4.  Immunochemical comparison between an oxacillin-hydrolyzing penicillinase of Aeromonas hydrophila and those mediated by R plasmids.

Authors:  T Sawai; I Takahashi; H Nakagawa; S Yamagishi
Journal:  J Bacteriol       Date:  1978-07       Impact factor: 3.490

5.  Cholera-like diarrhea in Canada. Report of a case associated with enterotoxigenic Escherichia coli and a toxin-producing Aeromonas hydrophila.

Authors:  M Gurwith; C Bourque; E Cameron; G Forrest; M Green
Journal:  Arch Intern Med       Date:  1977-10

6.  Freshwater wound infection due to Aeromonas hydrophila.

Authors:  P G Hanson; J Standridge; F Jarrett; D G Maki
Journal:  JAMA       Date:  1977-09-05       Impact factor: 56.272

Review 7.  Human aeromonas infections: a review of the literature and a case report of endocarditis.

Authors:  W A Davis; J G Kane; V F Garagusi
Journal:  Medicine (Baltimore)       Date:  1978-05       Impact factor: 1.889

8.  Gastroenteritis in children: a two-year review in Manitoba. I. Etiology.

Authors:  M J Gurwith; T W Williams
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

9.  Presence of glycerophospholipid: cholesterol acyltransferase and phospholipase in culture supernatant of Aeromonas hydrophila.

Authors:  S MacIntyre; J T Buckley
Journal:  J Bacteriol       Date:  1978-08       Impact factor: 3.490

10.  Isolation of enterotoxigenic Aeromonas from fish.

Authors:  Y Boulanger; R Lallier; G Cousineau
Journal:  Can J Microbiol       Date:  1977-09       Impact factor: 2.419

View more
  25 in total

1.  Fish cell lines as targets for bacterial cytotoxins.

Authors:  M Yadav; M D Hassan; J Albaladejo; A Ansary
Journal:  In Vitro Cell Dev Biol       Date:  1992-06

2.  A model for the density ofAeromonas hydrophila in Albemarle Sound, North Carolina.

Authors:  T C Hazen
Journal:  Microb Ecol       Date:  1983-07       Impact factor: 4.552

3.  Evaluation of the MALDI-TOF MS profiling for identification of newly described Aeromonas spp.

Authors:  Andrea Vávrová; Tereza Balážová; Ivo Sedláček; Ludmila Tvrzová; Ondrej Šedo
Journal:  Folia Microbiol (Praha)       Date:  2014-12-19       Impact factor: 2.099

4.  Beta-lactam resistance in Aeromonas spp. caused by inducible beta-lactamases active against penicillins, cephalosporins, and carbapenems.

Authors:  J S Bakken; C C Sanders; R B Clark; M Hori
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  Media for the isolation of Aeromonas hydrophila.

Authors:  B A Kay; C E Guerrero; R B Sack
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

6.  Immunological cross-reactivity of enterotoxins of Aeromonas hydrophila and cholera toxin.

Authors:  C James; M Dibley; V Burke; J Robinson; M Gracey
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

7.  Lack of correlation between known virulence properties of Aeromonas hydrophila and enteropathogenicity for humans.

Authors:  D R Morgan; P C Johnson; H L DuPont; T K Satterwhite; L V Wood
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Association of Aeromonas sobria with human infection.

Authors:  O P Daily; S W Joseph; J C Coolbaugh; R I Walker; B R Merrell; D M Rollins; R J Seidler; R R Colwell; C R Lissner
Journal:  J Clin Microbiol       Date:  1981-04       Impact factor: 5.948

9.  Invasion of HEp-2 cells by fecal isolates of Aeromonas hydrophila.

Authors:  M A Lawson; V Burke; B J Chang
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

10.  Effect of effluent from a nitrogen fertilizer factory and a pulp mill on the distribution and abundance of Aeromonas hydrophila in Albemarle Sound, North Carolina.

Authors:  T C Hazen; G W Esch
Journal:  Appl Environ Microbiol       Date:  1983-01       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.